Global Pediatric Drugs and Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pediatric Drugs and Vaccines market report explains the definition, types, applications, major countries, and major players of the Pediatric Drugs and Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Genentech Inc (USA)

    • Sanofi SA (France)

    • Novo Nordisk A/S (Denmark)

    • Novartis AG (Switzerland)

    • Shire Pharmaceuticals Group Plc (UK)

    • Abbott Laboratories (USA)

    • Merck & Co Inc (USA)

    • F Hoffmann-La Roche Ltd (Switzerland)

    • Janssen Biologics BV (USA)

    • Actelion Pharmaceuticals

    • Eli Lilly and Company (USA)

    • Pfizer Inc (USA)

    • Boehringer Ingelheim GmbH (Germany)

    • Amgen Inc (USA)

    • Shionogi Inc (USA)

    • Allergan Inc (USA)

    • AstraZeneca Plc (UK)

    • GlaxoSmithKline plc (UK)

    • Bristol-Myers Squibb Company (USA)

    By Type:

    • Diphtheria

    • Influenza

    • Hepatitis

    • Pneumococcal Diseases

    • Meningococcal Diseases

    • Mumps

    • Others

    By End-User:

    • Newborn

    • Infant

    • Child

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pediatric Drugs and Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pediatric Drugs and Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Pediatric Drugs and Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pediatric Drugs and Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pediatric Drugs and Vaccines Market- Recent Developments

    • 6.1 Pediatric Drugs and Vaccines Market News and Developments

    • 6.2 Pediatric Drugs and Vaccines Market Deals Landscape

    7 Pediatric Drugs and Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Pediatric Drugs and Vaccines Key Raw Materials

    • 7.2 Pediatric Drugs and Vaccines Price Trend of Key Raw Materials

    • 7.3 Pediatric Drugs and Vaccines Key Suppliers of Raw Materials

    • 7.4 Pediatric Drugs and Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Pediatric Drugs and Vaccines Cost Structure Analysis

      • 7.5.1 Pediatric Drugs and Vaccines Raw Materials Analysis

      • 7.5.2 Pediatric Drugs and Vaccines Labor Cost Analysis

      • 7.5.3 Pediatric Drugs and Vaccines Manufacturing Expenses Analysis

    8 Global Pediatric Drugs and Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pediatric Drugs and Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pediatric Drugs and Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pediatric Drugs and Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Pediatric Drugs and Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diphtheria Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hepatitis Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Pneumococcal Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Meningococcal Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Mumps Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pediatric Drugs and Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Newborn Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Infant Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Child Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pediatric Drugs and Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.2 UK Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.5 France Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.3 India Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Pediatric Drugs and Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pediatric Drugs and Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Pediatric Drugs and Vaccines Consumption (2017-2022)

    11 Global Pediatric Drugs and Vaccines Competitive Analysis

    • 11.1 Genentech Inc (USA)

      • 11.1.1 Genentech Inc (USA) Company Details

      • 11.1.2 Genentech Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Genentech Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.1.4 Genentech Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi SA (France)

      • 11.2.1 Sanofi SA (France) Company Details

      • 11.2.2 Sanofi SA (France) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi SA (France) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.2.4 Sanofi SA (France) Pediatric Drugs and Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Novo Nordisk A/S (Denmark)

      • 11.3.1 Novo Nordisk A/S (Denmark) Company Details

      • 11.3.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.3.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Novartis AG (Switzerland)

      • 11.4.1 Novartis AG (Switzerland) Company Details

      • 11.4.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.4.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Shire Pharmaceuticals Group Plc (UK)

      • 11.5.1 Shire Pharmaceuticals Group Plc (UK) Company Details

      • 11.5.2 Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.5.4 Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Abbott Laboratories (USA)

      • 11.6.1 Abbott Laboratories (USA) Company Details

      • 11.6.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.6.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Merck & Co Inc (USA)

      • 11.7.1 Merck & Co Inc (USA) Company Details

      • 11.7.2 Merck & Co Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Merck & Co Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.7.4 Merck & Co Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 F Hoffmann-La Roche Ltd (Switzerland)

      • 11.8.1 F Hoffmann-La Roche Ltd (Switzerland) Company Details

      • 11.8.2 F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.8.4 F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Janssen Biologics BV (USA)

      • 11.9.1 Janssen Biologics BV (USA) Company Details

      • 11.9.2 Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.9.4 Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Actelion Pharmaceuticals

      • 11.10.1 Actelion Pharmaceuticals Company Details

      • 11.10.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.10.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Eli Lilly and Company (USA)

      • 11.11.1 Eli Lilly and Company (USA) Company Details

      • 11.11.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.11.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Pfizer Inc (USA)

      • 11.12.1 Pfizer Inc (USA) Company Details

      • 11.12.2 Pfizer Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Pfizer Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.12.4 Pfizer Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Boehringer Ingelheim GmbH (Germany)

      • 11.13.1 Boehringer Ingelheim GmbH (Germany) Company Details

      • 11.13.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.13.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Amgen Inc (USA)

      • 11.14.1 Amgen Inc (USA) Company Details

      • 11.14.2 Amgen Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Amgen Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.14.4 Amgen Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Shionogi Inc (USA)

      • 11.15.1 Shionogi Inc (USA) Company Details

      • 11.15.2 Shionogi Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Shionogi Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.15.4 Shionogi Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Allergan Inc (USA)

      • 11.16.1 Allergan Inc (USA) Company Details

      • 11.16.2 Allergan Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Allergan Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.16.4 Allergan Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 AstraZeneca Plc (UK)

      • 11.17.1 AstraZeneca Plc (UK) Company Details

      • 11.17.2 AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.17.4 AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 GlaxoSmithKline plc (UK)

      • 11.18.1 GlaxoSmithKline plc (UK) Company Details

      • 11.18.2 GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.18.4 GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Bristol-Myers Squibb Company (USA)

      • 11.19.1 Bristol-Myers Squibb Company (USA) Company Details

      • 11.19.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

      • 11.19.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    12 Global Pediatric Drugs and Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Diphtheria Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Pneumococcal Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Meningococcal Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Mumps Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Newborn Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Infant Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Child Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pediatric Drugs and Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pediatric Drugs and Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pediatric Drugs and Vaccines

    • Figure of Pediatric Drugs and Vaccines Picture

    • Table Global Pediatric Drugs and Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pediatric Drugs and Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Diphtheria Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Mumps Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Newborn Consumption and Growth Rate (2017-2022)

    • Figure Global Infant Consumption and Growth Rate (2017-2022)

    • Figure Global Child Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Table North America Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure United States Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure Germany Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure China Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Pediatric Drugs and Vaccines Consumption by Country (2017-2022)

    • Figure Australia Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pediatric Drugs and Vaccines Consumption and Growth Rate (2017-2022)

    • Table Genentech Inc (USA) Company Details

    • Table Genentech Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Genentech Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Sanofi SA (France) Company Details

    • Table Sanofi SA (France) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA (France) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Sanofi SA (France) Pediatric Drugs and Vaccines Product Portfolio

    • Table Novo Nordisk A/S (Denmark) Company Details

    • Table Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio

    • Table Novartis AG (Switzerland) Company Details

    • Table Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

    • Table Shire Pharmaceuticals Group Plc (UK) Company Details

    • Table Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Shire Pharmaceuticals Group Plc (UK) Pediatric Drugs and Vaccines Product Portfolio

    • Table Abbott Laboratories (USA) Company Details

    • Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Merck & Co Inc (USA) Company Details

    • Table Merck & Co Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Merck & Co Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table F Hoffmann-La Roche Ltd (Switzerland) Company Details

    • Table F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table F Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio

    • Table Janssen Biologics BV (USA) Company Details

    • Table Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Janssen Biologics BV (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Actelion Pharmaceuticals Company Details

    • Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio

    • Table Eli Lilly and Company (USA) Company Details

    • Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Pfizer Inc (USA) Company Details

    • Table Pfizer Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Pfizer Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Boehringer Ingelheim GmbH (Germany) Company Details

    • Table Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio

    • Table Amgen Inc (USA) Company Details

    • Table Amgen Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Amgen Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Shionogi Inc (USA) Company Details

    • Table Shionogi Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shionogi Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Shionogi Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table Allergan Inc (USA) Company Details

    • Table Allergan Inc (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Inc (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Allergan Inc (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Table AstraZeneca Plc (UK) Company Details

    • Table AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table AstraZeneca Plc (UK) Pediatric Drugs and Vaccines Product Portfolio

    • Table GlaxoSmithKline plc (UK) Company Details

    • Table GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline plc (UK) Pediatric Drugs and Vaccines Product Portfolio

    • Table Bristol-Myers Squibb Company (USA) Company Details

    • Table Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Main Business and Markets Served

    • Table Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio

    • Figure Global Diphtheria Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mumps Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Newborn Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Child Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pediatric Drugs and Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pediatric Drugs and Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.